Skip to content

Ondansetron effect in cesarean

Effect of intravenous ondansetron in preventing hypotension in elective cesarean patients under spinal Anesthesia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201111138090N1
Enrollment
102
Registered
2012-02-28
Start date
2010-08-24
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal anesthesia. Other complications of spinal and epidural anaesthesia during pregnancy

Interventions

Intervention 1: Case group: 4 mg (2cc) ondansetron IV inject Slowly before spinal anesthesia. Intervention 2: Control group: 2cc sterile water IV injection before spinal anesthesia.
Prevention
Placebo
Case group: 4 mg (2cc) ondansetron IV inject Slowly before spinal anesthesia.
Control group: 2cc sterile water IV injection before spinal anesthesia.

Sponsors

Research vice Chancellorship, Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: pregnant healthy women who are candidate for elective cesarean section with spinal anesthesia. Exclusion criteria: motion sickness; hypertension; weight greater than 100kg; hepatic disease; migraine; allergy to ondansetron group drugs, using drugs that effect blood pressure or heart rate or serotonin receptor.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Bradycardia. Timepoint: Every 3 min till 10 min after anesthesia then every 5 min. Method of measurement: Heart rate per minute, automatic monitoring.;Hypotension. Timepoint: Every 3min till 10min after anesthesia, then every 5min till minute 30. Method of measurement: mmHg, automatic.

Secondary

MeasureTime frame
Itching. Timepoint: Every 10 minute after anesthesia till minute 30. Method of measurement: Question from patient, scoring: 0 no- 1 mild- 2 severe (need to treat).;Nausea and vomiting. Timepoint: Every 10 minute after anesthesia till minute 30. Method of measurement: Question from patient, scoring: 0 no- 1 yes.;Mean consumed ephedrine. Timepoint: After anesthesia until end of operation. Method of measurement: Milligram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Bita Malekianzadeh

Hamedan University of Medical Sciences

b.malekian@umsha.ac.ir+98 81 1835 0609

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026